Dermalogica, founded in 1986, has established itself as a leader in the Health and Wellness industry. Known for its professional-grade skincare education, products, and services, the company was created by skin therapist Jane Wurwand, who is a respected authority in skin therapy. This foundation in professional expertise has driven Dermalogica to become the leading professional skincare brand, with over 100,000 skin therapists in more than 100 countries using its products.
The company's emphasis on education and personalized skincare solutions sets it apart. Dermalogica offers skills-based training to a global community of skin therapists, ensuring a commitment to healthier skin for all. This approach is rooted in the belief that no two skin conditions are the same, and their customized regimens are frequently recommended by professionals.
Based in the United States, the company underscores the importance of human connection through the power of touch and communication. Notably, Dermalogica has not yet pursued recent investment rounds, presenting a potentially unique opportunity for future investors.